Completed PHASE2 INTERVENTIONAL 6-arm NCT00744276

A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease (FP1198-001)

A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Multicenter Evaluation of the Use of Topically Administered Danazol Versus Placebo in Subjects With Pain Associated With Fibrocystic Breast Disease

Sponsor: FemmePharma Global Healthcare, Inc.

Conditions Fibrocystic Disease of Breast

Interventions Placebo danazol

Updated 8 times since 2017 Last updated: May 25, 2010 Started: Jan 31, 2007 Primary completion: Apr 30, 2009 Completion: Jun 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Fibrocystic Disease of Breast and is currently completed. FemmePharma Global Healthcare, Inc. leads this study, which shows 8 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Apr 2022 — Jul 2024 [monthly]

Completed PHASE2
Jan 2021 — Apr 2022 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

FemmePharma Global Healthcare, Inc.

Data source: FemmePharma Global Healthcare, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beverly Hills, United States , Boynton Beach, United States , Champaign, United States , Chattanooga, United States , Chicago, United States , Columbus, United States , Denver, United States , Gainsville, United States , Indianapolis, United States , Jackson, United States and 19 more locations